OR

Browse By

ANZMTG 02. 12 RADICAL - A randomised controlled multicentre trial of imiquimod versus radiotherapy for lentigo maligna (LM) when staged surgical excision with 5mm margins is not possible, is refuse... (2015–2021)

Grant type:
Australia and New Zealand Melanoma Trials Group
Researchers:

  • Professor Peter Soyer

    MRFF-NG Practitioner Fellow
    Frazer Institute
    Faculty of Medicine
    MRFF-NG Practitioner Fellow
    Frazer Institute
    Faculty of Medicine
Funded by:
Melanoma Institute Australia